Amarin Corp Plcuk (AMRN) Restructuring Costs (2021 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Restructuring Costs of $40000.0 for Q2 2026, down 99.82% year-over-year from $22.8 million in Q2 2025, and down 98.8% quarter-over-quarter from $3.3 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Restructuring Costs (2021 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Restructuring Costs for 5 consecutive years, with $40000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Restructuring Costs fell 99.82% year-over-year to $40000.0; the TTM figure through Jun 2026 stood at $16.8 million (down 50.1% YoY), while the FY2025 annual figure was $36.2 million, changed N/A from the prior year.
- Restructuring Costs eased to $40000.0 in Q2 2026 per AMRN's latest filing, from $3.3 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $22.8 million in Q2 2025 and bottomed at -$180000.0 in Q4 2022.
- Historically, Restructuring Costs has averaged $5.8 million across 4 years, with a median of $3.5 million in 2022.
- Annual changes were most pronounced in 2023 — Restructuring Costs jumped 227.22% — and 2026, when it slumped 99.82%.
- Amarin Corp Plc\Uk's Restructuring Costs stood at -$180000.0 in 2022, then surged by 227.22% to $229000.0 in 2023, then soared by 1674.67% to $4.1 million in 2025, then tumbled by 99.02% to $40000.0 in 2026.
- Business Quant data shows AMRN's Restructuring Costs at $40000.0 in Q2 2026, $3.3 million in Q1 2026, and $4.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.66 Bn | 632.90 Bn | 17.26 Bn |
| 2 | AbbVie | 470.02 Bn | 463.46 Bn | 12.70 Bn |
| 3 | Merck | 379.06 Bn | 371.92 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.95 Bn | 295.26 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.68 Bn | 252.78 Bn | 12.86 Bn |
| 6 | Amgen | 236.97 Bn | 222.98 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.78 Bn | 179.60 Bn | 6.22 Bn |
| 8 | Pfizer | 161.51 Bn | 149.81 Bn | 10.94 Bn |
| 9 | Gsk | 105.54 Bn | 101.37 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.85 Bn | 5.53 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40,000.00 |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 9.41 Mn |
| Jun 30, 2025 | 22.76 Mn |
| Dec 31, 2023 | 229,000.00 |
| Sep 30, 2023 | 711,000.00 |
| Jun 30, 2023 | 10.03 Mn |
| Dec 31, 2022 | -180,000.00 |
| Sep 30, 2022 | 3.49 Mn |
| Jun 30, 2022 | 10.20 Mn |
| Dec 31, 2021 | -398,000.00 |
| Sep 30, 2021 | 14.12 Mn |